Dr. Vaishnavi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3400 Civic Center Blvd
2nd floor South Pavilion
Philadelphia, PA 19104Phone+1 215-662-7810Fax+1 215-615-4695
Summary
- Dr. Sanjeev Vaishnavi is a neurologist in Philadelphia, PA and is affiliated with multiple hospitals in the area, including Hospital of the University of Pennsylvania, Pennsylvania Hospital, and Penn Presbyterian Medical Center. He received his medical degree from Washington University School of Medicine in St. Louis and has been in practice 7 years. He specializes in neuroimaging, neurodegenerative, and dementia & geriatrics and is experienced in addiction medicine, dementia, alzheimer's disease, neurodegenerative disease, and positron emission tomography.
Education & Training
- Penn MedicineCognitive and Behavioral Neurology, 2014 - 2015
- University of Pennsylvania Health SystemResidency, Neurology, 2011 - 2014
- University of Pennsylvania Health SystemInternship, Internal Medicine, 2010 - 2011
- Washington University School of Medicine in St. LouisPhD, Neuroscience, 2003 - 2010
- Washington University in St. Louis School of MedicineClass of 2010
- Georgia Institute of TechnologyBS, Applied Biology, Summa Cum Laude, 1999 - 2002
Certifications & Licensure
- NJ State Medical License 2022 - 2025
- PA State Medical License 2014 - 2024
- American Board of Psychiatry and Neurology Neurology
- United Council for Neurologic SubspecialtiesBehavioral Neurology & Neuropsychiatry
Clinical Trials
- Clinical Trial of Solanezumab for Older Individuals Who May be at Risk for Memory Loss Start of enrollment: 2014 Feb 28
- A Study of CNP520 Versus Placebo in Participants at Risk for the Onset of Clinical Symptoms of Alzheimer's Disease Start of enrollment: 2017 Aug 03
- Study to Assess the Safety and Biological Activity of AMX0035 for the Treatment of Alzheimer's Disease Start of enrollment: 2018 Aug 27
- Join now to see all
Publications & Presentations
PubMed
- Biological effects of sodium phenylbutyrate and taurursodiol in Alzheimer's disease.Steven E Arnold, Suzanne Hendrix, Jessie Nicodemus-Johnson, Newman Knowlton, Victoria J Williams
Alzheimer's & Dementia. 2024-08-09 - 1 citationsPromoting Growth in Behavioral Neurology: A Path Forward.James R Bateman, Sylvia Josephy-Hernandez, Liana G Apostolova, Sheldon Benjamin, A M Barrett
Cognitive and Behavioral Neurology. 2024-06-01 - 5 citationsNon-tremor motor dysfunction in Lewy body dementias is associated with AD biomarkers.Ian M Walker, Katheryn A Cousins, Andrew Siderowf, John E Duda, James F Morley
Parkinsonism & Related Disorders. 2022-07-01
Journal Articles
- New Diagnostic Insights & Challenges of TreatmentSanjeev Vaishnavi, Practical Neurology, 6/2018
- Clinical Management of Patients with Alzheimer’s DiseaseRiddhi Patira, Sanjeev Vaishnavi, Practical Neurology, 6/2018
Books/Book Chapters
Press Mentions
- Alzheimer’s Drug Trialed by Penn Medicine Receives FDA ApprovalFebruary 2nd, 2023
- Alzheimer’s Lecanemab Drug Trial in People with No Symptoms, Some at Penn MedicineDecember 29th, 2022
- The Alzheimer’s MysteryNovember 16th, 2018
- Join now to see all
Grant Support
- Learning Related Modulation Of Resting Brain MetabolismNational Institute Of Neurological Disorders And Stroke2007–2010
Research History
- Medical Scientist Training Program (MD/PhD)Completed PhD in lab of Dr. Marcus Raichle, Washington University in St. Louis "The role of aerobic glycolysis in the resting human brain"2003 - 2010
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: